Most Ditch GLP-1 Drugs for Weight Loss Within a Year
Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly higher for patients without versus with type 2 diabetes (64.8% vs 46.5%), reported Ezekiel J. Emanuel, MD, PhD, of the University of Pennsylvania in Philadelphia, and colleagues.
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
WVU medicine is conducting a trial to combat weight gain after patients stop taking GLP-1 drugs such as Ozempic. Officials ...
However, Clinic Secret has emerged as a potential game-changer in weight loss by offering a clinically proven, accessible solution that leverages the power of GLP-1 medications. In this ...
A Comprehensive, Evidence-Based Review of GLP-1/GIP Agonists for Fitness and Wellness Professionals ...
GLP-1 medications such as Ozempic and Wegovy have had a transformative effect for those struggling with weight loss. Many ...
American host and television producer Oprah Winfrey recently shared her initial experience of taking the weight loss drug GLP ...
Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...
they should call their internist about possibly adjusting the dosage or stopping the medication. “We have other ways to control diabetes and weight loss,” she says. “There are many options ...
WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...
The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback